Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison - Chen, Wei; Yoshida, Soichiro; Miura, Noriyoshi; Fukuda, Shohei; Fukushima, Hiroshi; Waseda, Yuma; Tanaka, Hajime; Fujii, Yasuhisa (Frontiers in Oncology, 2025)